Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.10
-0.10 (-0.20%)
Jul 22, 2025, 1:34 PM CST
-32.11%
Market Cap3.58B
Revenue (ttm)n/a
Net Income (ttm)-150.37M
Shares Out71.31M
EPS (ttm)-2.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,230
Average Volume25,648
Open50.20
Previous Close50.20
Day's Range49.65 - 50.20
52-Week Range34.30 - 76.40
Beta0.11
RSI48.96
Earnings DateAug 11, 2025

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630 drug, for which is in Phase II clinical trial. It is also developing SNP-810 is in phase II clinical trial for use in Pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for acetamino... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.